Dr. Flavell is Sterling Professor of Immunobiology at Yale University School of Medicine and an Investigator of the Howard Hughes Medical Institute. His research is fundamental to our understanding of the molecular and cellular basis of innate and adaptive immunity.
Prior to returning to academia, Dr. Flavell was President and Chief Scientific Officer of Biogen Research Corporation for six years. Before Biogen, he was Head of the Laboratory of Gene Structure and Expression at the National Institute for Medical Research in Mill Hill, London and, before that, Assistant Professor at the University of Amsterdam. Dr. Flavell performed postdoctoral work in Amsterdam with Piet Borst and in Zurich with Charles Weissmann. He received his BSc (Honors) and Ph.D. in biochemistry from the University of Hull, England.
Dr. Flavell is a fellow of the Royal Society, a member of the National Academy of Sciences as well as the National Academy of Medicine. He is the recipient of several honors, including The Vilcek Prize in Biomedical Science and The William B. Coley Award for Distinguished Research in Basic and Tumor Immunology. He was recently honored as Distinguished Fellow by the American Association of Immunologists.
